Prof. Dr. Katharina Blankart

• Team Lead Institute of Health Economics and Policy

• Health policy

• Health economics

• Health Care Data Science

• Technology and innovation in health care

• Health Technology Assessment

• Katharina Blankart is a Professor of Health Economics at the Bern University of Applied Sciences, Department of Health. She is affiliated with the Hamburg Center for Health Economics at the University of Hamburg and the Leibniz Science Campus Ruhr in Essen, Germany.
  
  As the head of the Institute for Health Economics and Health Policy, she conducts efficiency analyses in the healthcare system and oversees the evaluation of new health technologies and care models. She also focuses on regulatory frameworks and their impact on innovations in healthcare. Her goal is to provide evidence-based support to health policy and decision-makers in Switzerland and beyond.
  
  Katharina Blankart studied Economics and Business Research at Ludwig Maximilian University of Munich and received her Ph.D. in Health Economics and Healthcare Management in 2012. Between 2012 and 2016, she was a post-doc at the University of Hamburg and Columbia University. From 2016 to 2023, she was an Assistant Professor of Empirical Health Economics at the University of Duisburg-Essen and a core member of the CINCH national health economics research center. She is currently a member of the extended board of the German Society for Health Economics.

• 2016-2023 Assisstant professor in empirical health economics University of Duisburg-Essen, Faculty of Economics and Business Administration and CINCH Health Economics Research Center
• 2015-2016 Visiting Officer of Research Columbia University in the City of New York, Business School
• 2012-2016 Head of junior research group and research associate University of Hamburg, Hamburg Business School and Hamburg Center for Health Economics

• 2012 Dr. oec. publ. (PhD in business administration) Ludwig-Maximilians-Universität Munich
• 2009-2011 Master of Business Research Ludwig-Maximilians-Universität Munich
• 2003-2008 Diplom-Volkswirtin (Economist) Ludwig-Maximilians-Universität Munich

• Blankart, K., & Vandoros, S. (2024). Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation (D. Gotham, Ed.; Vol. 19, Issue 5). Public Library of Science. https://doi.org/10.24451/arbor.21861

• Goetjes, E., & Blankart, K. (2024). Insurance barriers and inequalities in health care access: evidence from dual practice (Vol. 14, Issue 1). BioMed Central. https://doi.org/10.24451/arbor.21761

• Kommission Forschung Gesundheit

• Swiss Society of Health Economics sggö

• Deutsche Gesellschaft für Gesundheitsökonomie

• Verband der Hochschullehrer für Betriebswirtschaft

• Verein für Socialpolitik - Gesundheitsökonomischer Ausschuss

17. Wissenschaftspreis der Gesellschaft für Recht und Politik im Gesundheitswesen (GRPG) 2012

• German - Native or bilingual proficiency
• English - Full professional proficiency
• French - Elementary proficiency

• Switzerland
• Germany
• United States of America
• Ukraine